• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Migration (4003)
Patient Problems Edema (1820); No Code Available (3191)
Event Date 04/16/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).All patients had esrd, arteriovenous fistula and symptomatic occlusion of the cephalic arch or subclavian vein.Hypertension = 100% of patients.5/9 had diabetes mellitus.Review of the manufacturing records could not be performed as no lot number information was provided.The device was not returned.Consequently, direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no conclusion can be drawn.
 
Event Description
The following article was reviewed: ¿percutaneous costoclavicular bypass for thoracic outlet syndrome and cephalic arch occlusion in hemodialysis patients¿; jeffery hull, m.D.And james snyder, m.D.A retrospective review of percutaneous costoclavicular bypass patients between november 2014 ¿ december 2017 was performed.Stent grafts were placed subcutaneously over the clavicle from the fistula outflow (axillary or cephalic vein) into a jugular vein or collateral.The fistula outflow was cephalic in 67% (6/9) and axillary in 33% (3/9).The return vessel was external jugular in 78% (7/9) and internal jugular in 22% (2/9).Two overlapping viabahn stent grafts were used in 88% of cases (7/8) and 3 stent grafts in 1 case.At 12 months and 24 months, primary patency was 67% and 67%, and secondary patency was 89% and 78%, respectively.Complications included late thrombosis, secondary infection and stent migration.There were no anastomotic leaks or seromas associated with extravascular stent grafts.One patient demonstrated stent migration at the fistula after resolution of severe arm swelling.The migrating was treated with overlapping stent graft extension.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nick la fave
9285263030
MDR Report Key9844997
MDR Text Key193940189
Report Number2017233-2020-00195
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age60 YR
-
-